Delivery Order SPE2DB22D3501-SPE2DB25FXC31
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on September 29, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) valued at $17,968.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 29, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on October 31, 2025, with an ultimate completion date of November 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) on August 21, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) with a firm fixed price and no set-aside designation. The delivery order was awarded on July 24, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a routine pharmaceutical procurement to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, with no set-aside designation applied. The contract represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $35,936.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on September 18, 2025, with an ultimate completion date of October 9, 2025. The award is unclassified as a set-aside contract and represents a competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count packaging) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's substantial...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC31Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on August 29, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its extensive federal contracting portfolio with the Defense Logistics Agency. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to military healthcare systems and the Defense Health Agency. The company's federal contract awards demonstrate consistent capability to meet competitive procurement requirements across multiple therapeutic domains, supporting critical military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/29/25 |